Multiple Sclerosis Treatment

There is no cure for Multiple Sclerosis (MS). Treatment aims at delaying disease progression and preventing symptom relapse.

Management of MS involves of a number of healthcare professionals from different specializations who work as a team to help patients with this complex disorder. Some examples of the professionals involved in treating individuals with MS include neurologists, urologists, physiotherapists, occupational therapists, speech therapists, psychologists, social workers and nurses.

The treatment of MS is divided into three broad categories:

  • The management of specific symptoms of the disease
  • The treatment of MS attacks
  • Disease-modifying treatments to slow disease progression and prevent symptoms

Specific symptom management

This involves the prescription of treatments for specific symptoms such as:

  • Glasses to aid individuals with visual disturbances. People with jerky eye movements (nystagmus) may be prescribed a drug called gabapentin.
  • Muscle stiffness, spasm and tightness may be relieved with physiotherapy. In addition, muscle relaxants such as baclofen, tizanidine, diazepam, dantrolene or botox may be beneficial. Splints and braces may also be used for the correction of muscle spasm. Muscle spasm and pain may cause problems with manoeuvrability which can be improved with physiotherapy, exercise, splints and movement aids.
  • Nerve pain can be another major problem in MS and can be treated using carbamazepine, amitriptylline or gabapentin.
  • Psychological problems such as depression and anxiety are treated using appropriate medications and psychological therapy.
  • Bladder incontinence is treated using anti-cholinergic medicines such as oxybutynin or tolterodine. Mild to moderate constipation may be treated with dietary changes and laxatives.

Managing attacks


These are the main agents used to treat MS relapse. They reduce the inflammation that occurs during an attack and shorten the length of the relapse. They are usually administered intravenously and examples include methlprednisolone and prednisone.

Plasma exchange or plasmapheresis

This procedure may be used if a person is nonresponsive to steroids. In plasmapheresis, the blood cells are separated from plasma, mixed with a replacement solution and returned to the blood.

Disease modifying medications

Interferon beta

Interferon beta agents are used to slow disease progression in MS and reduce the length and severity of attacks. Examples include avonex, betaseron and rebif.

Glatiramer acetate

This drug is given as injections. Glatiramer acetate is thought to block the immune attack of myelin and is administered subcutaneously once a day.


This agent prevents the migration across the bood–brain barrier of certain immune cells that may damage the brain and spinal cord. Natalizumab is given as a monthly injection.

Further Reading

Last Updated: Jul 17, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 17). Multiple Sclerosis Treatment. News-Medical. Retrieved on December 03, 2023 from

  • MLA

    Mandal, Ananya. "Multiple Sclerosis Treatment". News-Medical. 03 December 2023. <>.

  • Chicago

    Mandal, Ananya. "Multiple Sclerosis Treatment". News-Medical. (accessed December 03, 2023).

  • Harvard

    Mandal, Ananya. 2023. Multiple Sclerosis Treatment. News-Medical, viewed 03 December 2023,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Novel multi-epitope subunit vaccine induces robust immune response against Epstein-Barr virus